Circulating complement (C3 and C4) for differentiation of SIRS from sepsis

被引:8
作者
Sungurtekin, Hulya [1 ]
Sungurtekin, Ugur [1 ]
Balci, Canan [1 ]
机构
[1] Pamukkale Univ, Sch Med, Dept Anesthesiol & Reanimat, Denizli, Turkey
关键词
sepsis; complement; SIRS;
D O I
10.1007/BF02850211
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The systemic inflammatory response of the body to invading microorganisms, called sepsis, leads to profound activation of the complement (C3 and C4) system. The present study was conducted to compare the use of serum C3 and C4 levels with C-reactive protein (CRP) and thrombocyte and leukocyte counts in differentiating patients with systemic inflammatory response syndrome (SIRS) from those with sepsis. Over a 6-mo period, all patients with SIRS or sepsis who stayed in the intensive care unit for > 24 h were enrolled in the study. At admission, each patient's clinical status was recorded, and blood was taken for laboratory analysis (complete blood count, CRP, C3, and C4). A total of 58 patients with SIRS and 41 patients with sepsis were admitted to the study. The mean +/- SD thrombocyte count was found to be significantly lower in septic patients (179,975 +/- 95,615) than in those with SIRS (243,165 +/- 123,706) (P=.005); no difference in plasma concentrations of CRP and levels of C3 and C4 was noted between groups. The thrombocyte count was determined to be the most reliable parameter for differentiating between SIRS and sepsis (highest area under the curve=0.656).
引用
收藏
页码:893 / 901
页数:9
相关论文
共 26 条
[1]   Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit [J].
Balci, C ;
Sungurtekin, H ;
Gürses, E ;
Sungurtekin, U ;
Kaptanoglu, B .
CRITICAL CARE, 2003, 7 (01) :85-90
[2]   RETRACTION: Platelet Function in Critically Ill Patients (vol 106, pg 899, 1994) (Retraction of Vol 106, Pg 899, 1994) [J].
Boldt, Joachim ;
Menges, Tilo ;
Wollbrueck, Matthias ;
Sonneborn, Stephan ;
Hempelmann, Gunter .
CHEST, 2023, 163 (04) :998-998
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]   Prediction of microbial infection and mortality in medical patients with fever:: Plasma procalcitonin, neutrophilic elastase-α1-antitrypsin, and lactoferrin compared with clinical variables [J].
Bossink, AWJ ;
Groeneveld, ABJ ;
Thijs, LG .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :398-407
[5]   The clinical host response to microbial infection in medical patients with fever [J].
Bossink, AWJ ;
Groeneveld, ABJ ;
Hack, CE ;
Thijs, LG .
CHEST, 1999, 116 (02) :380-390
[6]   PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME [J].
CASEY, LC ;
BALK, RA ;
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) :771-778
[7]   Sepsis and serum cytokine concentrations [J].
Damas, P ;
Canivet, JL ;
DeGroote, D ;
Vrindts, Y ;
Albert, A ;
Franchimont, P ;
Lamy, M .
CRITICAL CARE MEDICINE, 1997, 25 (03) :405-412
[8]   Complement factors and their receptors [J].
Ember, JA ;
Hugli, TE .
IMMUNOPHARMACOLOGY, 1997, 38 (1-2) :3-15
[9]  
GARDINALI M, 1992, ARCH SURG-CHICAGO, V127, P1219
[10]   Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection [J].
Groeneveld, ABJ ;
Tacx, AN ;
Bossink, AWJ ;
van Mierlo, GJ ;
Hack, CE .
CLINICAL IMMUNOLOGY, 2003, 106 (02) :106-115